MedTrace Logo

Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation

NCT01603030 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2012-05-22

No results posted yet for this study

Summary

This is a Unicentric, double-blind, randomized, two-arm, parallel-group study to demonstrate the efficacy of moxifloxacin/prednisolone acetate fixed combination compared with individual administration of moxifloxacin + acetate Prednisolone Eye drops in Prevention of Post Operative Inflammation and Infection in LASIK surgery.

Conditions

  • Eye Infection/Inflammation Other

Interventions

DRUG

moxifloxacin 0,5% + prednisolone 1%

1 gtt, 4x/day, 15 days

DRUG

moxifloxacin/prednisolone combination

1 gtt, 4x/day, 15 days

Sponsors & Collaborators

  • Adapt Produtos Oftalmológicos Ltda.

    lead INDUSTRY

Principal Investigators

  • Cristina Mucioli, Dra. · Universidade Federal de São Paulo - Hospital São Paulo - UNIFESP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2012-08-31
Completion
2012-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01603030 on ClinicalTrials.gov